Transurethral radiofrequency needle ablation of the prostate (TUNA) may be considered medically necessary as a treatment of benign prostatic hypertrophy.
Candidates for this procedure are men over 45 years of age with a Prostate with an estimated weight of 80 grams or less, volume of 90 ml or less, with a flow maximum urinal of less than 12cc per second and the urine volume is less than 300cc. Hyperplasia should be predominantly in the lateral lobes and that
demonstrate the symptoms described above for more than three months.
Those patients in whom TURP is contraindicated are included as candidates, tales like anticoagulated patients, hemophiliacs, patients with serious problems cardiovascular or respiratory and very old patients.
Radiofrequency ablation of the prostate is considered for payment as expressed in this policy.